Curitiba, Brazil
Previneo, founded in 2015, is a pioneering HealthTech from Brazil, distinguished as the nation’s first company to utilize Artificial Intelligence for disease prevention. Operating in the Digital Health industry, Previneo aims to create "Smarter Health for a Better World."
The company has established itself as an innovative leader, already reaching approximately 100,000 individuals through partnerships with public and private sectors. Its offerings include AI-driven digital self-assessment modules that provide customized risk evaluations for various diseases, thereby enabling informed decision-making for patients and healthcare professionals, potentially saving lives.
Notably, Previneo received the Desafio Roche™ 2019 award, allowing participation in Roche Diagnostics’ Digital Health Accelerator in Munich, Germany. Despite its accolades, Previneo's last investment round is not publicly disclosed, presenting a potential opportunity for investors seeking to support a high-impact health innovation company with proven credentials and international experience.
